Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

1.

Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.

Goldman JL, Chung WH, Lee BR, Chen CB, Lu CW, Hoetzenecker W, Micheletti R, Yasuda SU, Margolis DJ, Shear NH, Struewing JP, Pirmohamed M.

Eur J Clin Pharmacol. 2019 Jun 29. doi: 10.1007/s00228-019-02710-4. [Epub ahead of print]

PMID:
31254013
2.

Treatment Outcomes of Immune-Related Cutaneous Adverse Events.

Phillips GS, Wu J, Hellmann MD, Postow MA, Rizvi NA, Freites-Martinez A, Chan D, Dusza S, Motzer RJ, Rosenberg JE, Callahan MK, Chapman PB, Geskin L, Lopez AT, Reed VA, Fabbrocini G, Annunziata MC, Kukoyi O, Pabani A, Yang CH, Chung WH, Markova A, Lacouture ME.

J Clin Oncol. 2019 Jun 19:JCO1802141. doi: 10.1200/JCO.18.02141. [Epub ahead of print]

PMID:
31216228
3.

The Mechanism of Onychomadesis (Nail Shedding) and Beau's Lines Following Hand-Foot-Mouth Disease.

Chiu HH, Liu MT, Chung WH, Ko YS, Lu CF, Lan CE, Lu CW, Wei KC.

Viruses. 2019 Jun 6;11(6). pii: E522. doi: 10.3390/v11060522.

4.

The 10th International Congress on Cutaneous Adverse Drug Reactions, Shimane, Japan, 2018: Focus on New Discoveries.

Olteanu C, Shear NH, Morita E, Chung WH, Niihara H, Matsukura S, Hashimoto R, Dodiuk-Gad RP.

Drug Saf. 2019 Jun;42(6):797-801. doi: 10.1007/s40264-019-00818-1. No abstract available.

PMID:
31037651
5.

HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS/TEN in Europeans.

Mockenhaupt M, Wang CW, Hung SI, Sekula P, Schmidt AH, Pan RY, Chen CB, Dunant A, Gouvello SL, Schumacher M, Valeyrie-Allanore L, Bellon T, Kardaun SH, Jan YS, Chung WH, Roujeau JC; RegiSCAR group.

Allergy. 2019 Apr 11. doi: 10.1111/all.13821. [Epub ahead of print] No abstract available.

PMID:
30972788
6.

Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.

Goldman JL, Chung WH, Lee BR, Chen CB, Lu CW, Hoetzenecker W, Micheletti R, Yasuda SU, Margolis DJ, Shear NH, Struewing JP, Pirmohamed M.

Eur J Clin Pharmacol. 2019 Aug;75(8):1135-1141. doi: 10.1007/s00228-019-02670-9. Epub 2019 Mar 27. Erratum in: Eur J Clin Pharmacol. 2019 Jun 29;:.

PMID:
30918988
7.

Erratum to "An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity".

Chen CB, Abe R, Pan RY, Wang CW, Hung SI, Tsai YG, Chung WH.

J Immunol Res. 2019 Jan 31;2019:2489429. doi: 10.1155/2019/2489429. eCollection 2019.

8.

Increased Type 2 Innate Lymphoid Cells in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome.

Tsai YG, Liou JH, Hung SI, Chen CB, Chiu TM, Wang CW, Chung WH.

J Invest Dermatol. 2019 Feb 5. pii: S0022-202X(19)30100-9. doi: 10.1016/j.jid.2018.10.048. [Epub ahead of print]

PMID:
30735685
9.

Varenicline-induced symmetrical drug-related intertriginous and flexural exanthema.

Cheng CY, Wang CW, Wang FY, Chung WH.

Indian J Dermatol Venereol Leprol. 2019 Mar-Apr;85(2):209-211. doi: 10.4103/ijdvl.IJDVL_768_17. No abstract available.

10.

Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis.

Chen CH, Chen CB, Chang CJ, Lin YJ, Wang CW, Chi CC, Lu CW, Chen WT, Pan RY, Su SC, Hsu LA, Chang YC, Yu KH, Wu YJ, Lin KM, Hung SI, Chen SM, Chung WH.

Clin Pharmacol Ther. 2019 Jan 28. doi: 10.1002/cpt.1377. [Epub ahead of print]

PMID:
30690722
11.

Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens.

Pan RY, Chung WH, Chu MT, Chen SJ, Chen HC, Zheng L, Hung SI.

J Immunol Res. 2018 Dec 19;2018:4325874. doi: 10.1155/2018/4325874. eCollection 2018. Review.

12.

Rhein, An Anthraquinone Drug, Suppresses the NLRP3 Inflammasome and Macrophage Activation in Urate Crystal-Induced Gouty Inflammation.

Chang WC, Chu MT, Hsu CY, Wu YJ, Lee JY, Chen TJ, Chung WH, Chen DY, Hung SI.

Am J Chin Med. 2019;47(1):135-151. doi: 10.1142/S0192415X19500071. Epub 2019 Jan 7.

PMID:
30612459
13.

Controversies in drug allergy: Testing for delayed reactions.

Phillips EJ, Bigliardi P, Bircher AJ, Broyles A, Chang YS, Chung WH, Lehloenya R, Mockenhaupt M, Peter J, Pirmohamed M, Roujeau JC, Shear NH, Tanno LK, Trubiano J, Valluzzi R, Barbaud A.

J Allergy Clin Immunol. 2019 Jan;143(1):66-73. doi: 10.1016/j.jaci.2018.10.030. Epub 2018 Dec 17. Review.

PMID:
30573342
14.

Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis.

Meier-Schiesser B, Feldmeyer L, Jankovic D, Mellett M, Satoh TK, Yerly D, Navarini A, Abe R, Yawalkar N, Chung WH, French LE, Contassot E.

J Invest Dermatol. 2019 Apr;139(4):848-858. doi: 10.1016/j.jid.2018.10.023. Epub 2018 Nov 2.

PMID:
30395846
15.

Utility of human leukocyte antigen-B*58: 01 genotyping and patient outcomes.

Ke CH, Chung WH, Tain YL, Huang YB, Wen YH, Chuang HY, Hsu CN.

Pharmacogenet Genomics. 2019 Jan;29(1):1-8. doi: 10.1097/FPC.0000000000000359.

PMID:
30379713
16.

HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians.

Su SC, Chen CB, Chang WC, Wang CW, Fan WL, Lu LY, Nakamura R, Saito Y, Ueta M, Kinoshita S, Sukasem C, Yampayon K, Kijsanayotin P, Nakkam N, Saksit N, Tassaneeyakul W, Aihara M, Lin YJ, Chang CJ, Wu T, Hung SI, Chung WH.

Clin Pharmacol Ther. 2019 Feb;105(2):476-485. doi: 10.1002/cpt.1190. Epub 2018 Sep 30.

PMID:
30270535
17.

The influence of acute kidney injury on the outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis: The prognostic value of KDIGO staging.

Lee TH, Lee CC, Ng CY, Chang MY, Chang SW, Fan PC, Chung WH, Tian YC, Chen YC, Chang CH.

PLoS One. 2018 Sep 7;13(9):e0203642. doi: 10.1371/journal.pone.0203642. eCollection 2018.

18.

The effect of levamisole in the treatment of recalcitrant recurrent erythema multiforme major: An observational study.

Liu RF, Chen CB, Hui RCY, Kuan YZ, Chung WH.

J Dermatol Sci. 2018 Oct;92(1):38-44. doi: 10.1016/j.jdermsci.2018.08.002. Epub 2018 Aug 8.

PMID:
30143369
19.

The application of 595-nm pulsed dye laser for vascular anomalies in a Chinese population: a 10-year experience.

Lin MY, Lin CS, Hu S, Chang JM, Chung WH, Zhang ZY, Chang SC, Huo YP.

J Cosmet Laser Ther. 2019;21(3):171-178. doi: 10.1080/14764172.2018.1502450. Epub 2018 Jul 27.

PMID:
30052093
20.

New Advances in Drug Hypersensitivity Research and Treatment.

Tsai YG, Chung WH, Abe R, Tassaneeyakul W.

J Immunol Res. 2018 Jun 21;2018:9345078. doi: 10.1155/2018/9345078. eCollection 2018. No abstract available.

Supplemental Content

Loading ...
Support Center